ID/IQ parent award for phase I clinical trials for development of neurotherapeutics - duke university, dcri

Ended Awarded Last action

Contract number
HHSN271201600004I
Awardee
Awarding agency
Task orders
3 $3,931,176 obligated

Award facts

Opportunity
Combined order value
$3,931,176 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 20% used
$19,500,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Funding agency
National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Cost No Fee

Award details come from SAM.gov/FPDS.

Task orders

Task order Ordering agency Obligated Awarded
Healthy volunteer study of CSF fluid and oral bioavailability of RR-HNK 75N95021F00001 National Institute on Drug Abuse (NIH) $405,770
Phase I single ascending dose and multiple ascending dose study of 2R,6R-hydroxynorketamine 75N95018F00002 National Institute on Drug Abuse (NIH) $3,115,865
Task order #001 - performance area a - administrative and overall clinical operations support HHSN27100001 National Institute on Drug Abuse (NIH) $409,541

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00009 · Phase I clinical trials for development of neurotherapeutics $0
Supplemental Agreement for work within scope P00008 · Incorporate IPP clause - phase I clinical trials for development of neurotherapeutics $0
Supplemental Agreement for work within scope P00007 $0
Supplemental Agreement for work within scope P00006 $0
Other Administrative Action P00005 · Phase I clinical trials for development of neurotherapeutics MOD P00005: unilateral COR & alternate COR change $0
Change Order P00004 · Parent award for phase I clinical trials for development of neurotherapeutics - duke university, dcri - MOD P00004: incorporate far 52.204-25 $0
Other Administrative Action P00003 $0
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $0

Quick answers

Who was awarded contract HHSN271201600004I?

HHSN271201600004I was awarded to Duke University by National Institute on Drug Abuse (National Institutes of Health) on July 8, 2016.

How much is contract HHSN271201600004I worth?

Orders under HHSN271201600004I have obligated $3,931,176. HHSN271201600004I's own ceiling is $19,500,000.

How many orders have been placed under contract HHSN271201600004I?

3 orders have been placed under HHSN271201600004I, the latest on September 30, 2021.

Which agency awarded contract HHSN271201600004I?

National Institute on Drug Abuse (National Institutes of Health) awarded HHSN271201600004I, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).

Who can order from contract HHSN271201600004I?

HHSN271201600004I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN271201600004I part of a contract vehicle?

Yes. HHSN271201600004I is part of Phase I Clinical Trials for Development of Neurotherapeutics.

Was contract HHSN271201600004I competed?

The extent of competition for HHSN271201600004I was full and open competition. The government received 4 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login